Consistent with a role in genome stability, CDK12 was identified as a likely tumor suppressor for ovarian cancer several years ago [1,2], and evidence continues to accumulate linking CDK12 alterations to ovarian and other types of cancer [25,26]. Here, CDK12 is linked to ovarian cancer.